Literature DB >> 377891

Transfer of bromocriptine across the blood-brain barrier in man.

M L Friis, O B Paulson, M M Hertz.   

Abstract

The transfer of 14C-bromocriptine across the blood-brain barrier was studied in 10 patients using the double indicator single injection method. The extraction (E) of bromocriptine was 8 % (quartiles: 6 and 14 %). Based on the results the cerebral uptake velocity of bromocriptine was calculated assuming constant arterial drug concentration. Its T 1/2 was found to be 12--24 minutes, depending on the tissue-blood partition coefficient.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377891     DOI: 10.1111/j.1600-0404.1979.tb02915.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.

Authors:  Dirk Deleu; Margaret G Northway; Yolande Hanssens
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.

Authors:  G Maurer; E Schreier; S Delaborde; R Nufer; A P Shukla
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

3.  Identification of approved drugs that inhibit the binding of amyloid β oligomers to ephrin type-B receptor 2.

Authors:  Koichiro Suzuki; Takahiro Aimi; Tomoaki Ishihara; Tohru Mizushima
Journal:  FEBS Open Bio       Date:  2016-04-01       Impact factor: 2.693

4.  Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease.

Authors:  Akihiro Yamaguchi; Kei-Ichi Ishikawa; Tsuyoshi Inoshita; Kahori Shiba-Fukushima; Shinji Saiki; Taku Hatano; Akio Mori; Yutaka Oji; Ayami Okuzumi; Yuanzhe Li; Manabu Funayama; Yuzuru Imai; Nobutaka Hattori; Wado Akamatsu
Journal:  Stem Cell Reports       Date:  2020-05-28       Impact factor: 7.765

Review 5.  Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Authors:  Dag Nyholm
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 5.577

6.  Dopamine receptor D1- and D2-agonists do not spark brown adipose tissue thermogenesis in mice.

Authors:  Francesca-Maria Raffaelli; Julia Resch; Rebecca Oelkrug; K Alexander Iwen; Jens Mittag
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.